Display options
Cite
El Sheikh SS, Domin J, Tomtitchong P, et al. Topographical expression of class IA and class II phosphoinositide 3-kinase enzymes in normal human tissues is consistent with a role in differentiation. BMC Clin Pathol. 2003;3(1):4doi: 10.1186/1472-6890-3-4.
El Sheikh, S. S., Domin, J., Tomtitchong, P., Abel, P., Stamp, G., & Lalani, E. N. (2003). Topographical expression of class IA and class II phosphoinositide 3-kinase enzymes in normal human tissues is consistent with a role in differentiation. BMC clinical pathology, 3(1), 4. https://doi.org/10.1186/1472-6890-3-4
El Sheikh, Soha Salama, et al. "Topographical expression of class IA and class II phosphoinositide 3-kinase enzymes in normal human tissues is consistent with a role in differentiation." BMC clinical pathology vol. 3,1 (2003): 4. doi: https://doi.org/10.1186/1472-6890-3-4
El Sheikh SS, Domin J, Tomtitchong P, Abel P, Stamp G, Lalani EN. Topographical expression of class IA and class II phosphoinositide 3-kinase enzymes in normal human tissues is consistent with a role in differentiation. BMC Clin Pathol. 2003 Oct 16;3(1):4. doi: 10.1186/1472-6890-3-4. PMID: 14563213; PMCID: PMC280660.
Copy Download .nbib Format: NLM
Share it on

BMC Clin Pathol. 2003 Oct 16;3(1):4. doi: 10.1186/1472-6890-3-4.

Topographical expression of class IA and class II phosphoinositide 3-kinase enzymes in normal human tissues is consistent with a role in differentiation.

BMC clinical pathology

Soha Salama El Sheikh, Jan Domin, Prakitpunthu Tomtitchong, Paul Abel, Gordon Stamp, El-Nasir Lalani

Affiliations

  1. Department of Histopathology, L Block, Hammersmith Hospital Campus, Imperial College, London W12 0NN, UK. [email protected]

PMID: 14563213 PMCID: PMC280660 DOI: 10.1186/1472-6890-3-4

Abstract

BACKGROUND: Growth factor, cytokine and chemokine-induced activation of PI3K enzymes constitutes the start of a complex signalling cascade, which ultimately mediates cellular activities such as proliferation, differentiation, chemotaxis, survival, trafficking, and glucose homeostasis. The PI3K enzyme family is divided into 3 classes; class I (subdivided into IA and IB), class II (PI3K-C2alpha, PI3K-C2beta and PI3K-C2gamma) and class III PI3K. Expression of these enzymes in human tissue has not been clearly defined. METHODS: In this study, we analysed the immunohistochemical topographical expression profile of class IA (anti-p85 adaptor) and class II PI3K (PI3K-C2alpha and PI3K-C2beta) enzymes in 104 formalin-fixed, paraffin embedded normal adult human (age 33-71 years, median 44 years) tissue specimens including those from the gastrointestinal, genitourinary, hepatobiliary, endocrine, integument and lymphoid systems. Antibody specificity was verified by Western blotting of cell lysates and peptide blocking studies. Immunohistochemistry intensity was scored from undetectable to strong. RESULTS: PI3K enzymes were expressed in selected cell populations of epithelial or mesenchymal origin. Columnar epithelium and transitional epithelia were reactive but mucous secreting and stratified squamous epithelia were not. Mesenchymal elements (smooth muscle and endothelial cells) and glomerular epithelium were only expressed PI3K-C2alpha while ganglion cells expressed p85 and PI3K-C2beta. All three enzymes were detected in macrophages, which served as an internal positive control. None of the three PI3K isozymes was detected in the stem cell/progenitor compartments or in B lymphocyte aggregates. CONCLUSIONS: Taken together, these data suggest that PI3K enzyme distribution is not ubiquitous but expressed selectively in fully differentiated, non-proliferating cells. Identification of the normal in vivo expression pattern of class IA and class II PI3K paves the way for further analyses which will clarify the role played by these enzymes in inflammatory, neoplastic and other human disease conditions.

References

  1. J Biol Chem. 1999 May 21;274(21):14529-32 - PubMed
  2. Proc Natl Acad Sci U S A. 1997 Apr 29;94(9):4330-5 - PubMed
  3. J Biol Chem. 2000 Nov 17;275(46):35942-52 - PubMed
  4. J Cell Biol. 2001 Oct 1;155(1):15-7 - PubMed
  5. J Biol Chem. 1998 Dec 4;273(49):33082-90 - PubMed
  6. Biochim Biophys Acta. 2002 Oct 10;1584(2-3):73-80 - PubMed
  7. Trends Cell Biol. 2002 Apr;12(4):185-92 - PubMed
  8. Sci STKE. 2001 Jan 16;2001(65):pe1 - PubMed
  9. Natl Cancer Inst Monogr. 1964 May;14:119-50 - PubMed
  10. Langenbecks Arch Surg. 2001 Jul;386(4):293-301 - PubMed
  11. Annu Rev Biochem. 2001;70:535-602 - PubMed
  12. EMBO J. 2000 Mar 15;19(6):1312-26 - PubMed
  13. J Biol Chem. 2001 May 25;276(21):17754-61 - PubMed
  14. Gastroenterology. 2002 Oct;123(4):1163-78 - PubMed
  15. J Histochem Cytochem. 2003 Mar;51(3):275-83 - PubMed
  16. Mol Med Today. 2000 Sep;6(9):347-57 - PubMed
  17. Mol Pathol. 2003 Apr;56(2):86-96 - PubMed
  18. Nat Genet. 1999 Feb;21(2):230-5 - PubMed
  19. J Pathol. 2002 Nov;198(3):335-42 - PubMed
  20. Mol Cell Biol. 1998 Oct;18(10):5699-711 - PubMed
  21. J Biol Chem. 1998 Oct 2;273(40):25987-95 - PubMed
  22. Exp Cell Res. 1999 Nov 25;253(1):239-54 - PubMed
  23. Cell Mol Biol (Noisy-le-grand). 1998 Sep;44(6):973-83 - PubMed
  24. J Biol Chem. 2000 Apr 21;275(16):11943-50 - PubMed
  25. Annu Rev Cell Dev Biol. 2001;17:615-75 - PubMed
  26. EMBO J. 1995 Jul 17;14(14):3339-48 - PubMed
  27. J Cell Biol. 2001 Oct 1;155(1):19-25 - PubMed
  28. Biochem J. 1997 Aug 15;326 ( Pt 1):139-47 - PubMed
  29. Curr Opin Genet Dev. 2001 Feb;11(1):91-7 - PubMed
  30. J Biol Chem. 2000 Jul 21;275(29):21960-8 - PubMed
  31. FEBS Lett. 2002 Oct 9;529(2-3):268-74 - PubMed
  32. Mol Cell Biol. 2002 Feb;22(3):965-77 - PubMed
  33. J Biol Chem. 1997 Mar 21;272(12):7873-82 - PubMed
  34. Cancer Res. 1998 Jan 1;58(1):1-4 - PubMed
  35. J Biol Chem. 2003 Feb 14;278(7):5099-108 - PubMed
  36. J Pathol. 2002 Jul;197(4):492-509 - PubMed
  37. Cell. 1987 Sep 25;50(7):1031-7 - PubMed
  38. Genomics. 1998 Dec 15;54(3):569-74 - PubMed
  39. J Clin Invest. 2002 Jan;109(1):141-9 - PubMed
  40. J Biol Chem. 2002 Mar 8;277(10):8226-34 - PubMed
  41. Nat Genet. 2002 Sep;32(1):90-1 - PubMed
  42. FEBS Lett. 1997 Jun 23;410(1):91-5 - PubMed
  43. J Cell Biol. 2000 Oct 16;151(2):249-62 - PubMed
  44. Science. 1999 Jan 15;283(5400):390-2 - PubMed
  45. Biochem Biophys Res Commun. 1997 Jun 9;235(1):130-7 - PubMed
  46. Mol Cell Biol. 1998 Mar;18(3):1379-87 - PubMed
  47. Gastroenterology. 2001 May;120(6):1381-92 - PubMed
  48. Science. 1999 Jan 15;283(5400):393-7 - PubMed
  49. J Cell Sci. 2001 Apr;114(Pt 8):1439-45 - PubMed
  50. Mol Cell Biol. 2000 Jun;20(11):3817-30 - PubMed
  51. Mol Cell Biol. 2001 Oct;21(19):6660-7 - PubMed

Publication Types